Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative multiomics analysis of cell physiological state after culture in a basket bioreactor. | Sci Rep | 2022 | 36424406 | PubTator, text mining | PubMed |
| Advances in the Lung Cancer Immunotherapy Approaches. | Vaccines (Basel) | 2022 | 36423060 | PubTator, text mining | PubMed |
| Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment. | Arch Pharm Res | 2022 | 36422795 | PubTator, text mining | PubMed |
| Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment. | Curr Oncol | 2022 | 36421358 | PubTator, text mining | PubMed |
| Strategies to enhance CAR-T persistence. | Biomark Res | 2022 | 36419115 | PubTator, text mining | PubMed |
| CAR-T cell combination therapy: the next revolution in cancer treatment. | Cancer Cell Int | 2022 | 36419058 | PubTator, text mining | PubMed |
| Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins. | Front Immunol | 2022 | 36405686 | PubTator, text mining | PubMed |
| Integrating transcription factor occupancy with transcriptome-wide association analysis identifies susceptibility genes in human cancers. | Nat Commun | 2022 | 36402776 | PubTator, text mining | PubMed |
| PPARγ lipodystrophy mutants reveal intermolecular interactions required for enhancer activation. | Nat Commun | 2022 | 36402763 | PubTator, text mining | PubMed |
| A PD-L1-targeting chimeric switch receptor enhances efficacy of CAR-T cell for pleural and peritoneal metastasis. | Signal Transduct Target Ther | 2022 | 36402752 | PubTator, text mining | PubMed |
| Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics. | J Transl Med | 2022 | 36401282 | PubTator, text mining | PubMed |
| Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma? | ESMO Open | 2022 | 36399952 | PubTator, text mining | PubMed |
| Recent progress of gene circuit designs in immune cell therapies. | Cell Syst | 2022 | 36395726 | PubTator, text mining | PubMed |
| A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology. | Front Immunol | 2022 | 36389765 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T cells applied to solid tumors. | Front Immunol | 2022 | 36389701 | PubTator, text mining | PubMed |
| Immunotherapy for the treatment of multiple myeloma. | Front Immunol | 2022 | 36389674 | PubTator, text mining | PubMed |
| Next generations of CAR-T cells - new therapeutic opportunities in hematology? | Front Immunol | 2022 | 36389658 | PubTator, text mining | PubMed |
| Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma. | Front Neurol | 2022 | 36388191 | PubTator, text mining | PubMed |
| Regulation mechanism of ferroptosis and its research progress in tumor immunotherapy. | Front Mol Biosci | 2022 | 36387286 | PubTator, text mining | PubMed |
| Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer. | Front Oncol | 2022 | 36387071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=50